Marinus Pharmaceuticals, Inc.

MRNS · NASDAQ
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Assets
Cash & Equivalents$120,572$240,551$122,927$138,509
Short-Term Investments$29,716$0$0$0
Receivables$3,799$6,348$3,186$1,646
Inventory$2,413$77-$9,308-$6,284
Other Curr. Assets$8,746$5,402$5,565$4,638
Total Curr. Assets$165,246$240,551$122,927$140,155
Property Plant & Equip (Net)$4,843$4,236$2,499$1,945
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$1,474
Tax Assets$0$0$0$0
Other NC Assets$819$14,731$11,414$6,888
Total NC Assets$5,662$18,967$13,913$10,307
Other Assets$0$0$0$0
Total Assets$170,908$259,518$136,840$150,462
Liabilities
Payables$4,003$4,461$3,126$2,211
Short-Term Debt$14,536$1,657$556$510
Tax Payable$0$2,445$0$0
Deferred Revenue$0$0$15,651$0
Other Curr. Liab.$22,085$16,454$36,884$8,008
Total Curr. Liab.$40,624$54,874$40,566$10,729
LT Debt$95,822$72,359$42,788$2,534
Deferred Rev, NC$17,545$16,285$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$152$29,857$0$0
Total NC Liab.$113,519$88,644$42,788$2,534
Other Liabilities$0$0$0$0
Cap. Leases$1,407$1,978$2,535$3,044
Total Liabilities$154,143$143,518$83,354$13,263
Equity
Pref Stock$0$4,043$4,302$4,469
Common Stock$55$50$37$37
Retained Earnings-$571,926-$430,521-$410,705-$311,929
AOCI-$20$0$0-$0
Other Equity$588,656$542,428$459,852$444,622
Total Equity$16,765$116,000$53,486$137,199
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$170,908$259,518$136,840$150,462
Net Debt-$10,214-$166,535-$79,583-$135,465
Marinus Pharmaceuticals, Inc. (MRNS) Financial Statements & Key Stats | AlphaPilot